Journal of Gastrointestinal Oncology


Publication Venue For

  • Efficacy and tolerability of the combination of nano-liposomal irinotecan and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma: Post-approval clinic experience.  12:464-473. 2021
  • Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma.  10:554-561. 2019
  • Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma.  10:695-702. 2019
  • Open surgical treatment for esophageal cancer: Transhiatal vs. transthoracic, does it really matter?.  10:783-788. 2019
  • Germline pharmacogenomics of DPYD*9A (c.85T>C) variant in patients with gastrointestinal malignancies treated with fluoropyrimidines.  9:416-424. 2018
  • A case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology.  7:S96-S99. 2016
  • Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.  7:189-195. 2016
  • Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: Implications for adjuvant radiotherapy.  7:239-247. 2016
  • Imaging preoperatively for pancreatic adenocarcinoma.  6:343-357. 2015
  • Adjuvant chemoradiation for pancreatic cancer: What does the evidence tell us?.  5:166-177. 2014
  • Socioeconomic status, p53 abnormalities, and colorectal cancer.  4:40-44. 2013
  • Bax expression is a candidate prognostic and predictive marker of colorectal cancer..  1:76-89. 2010
  • International Standard Serial Number (issn)

  • 2078-6891
  • Electronic International Standard Serial Number (eissn)

  • 2219-679X